Piramal Pharma Limited (BOM:543635)

Market Cap	255.12B
Revenue (ttm)	91.34B
Net Income (ttm)	980.70M
Shares Out	n/a
EPS (ttm)	0.73
PE Ratio	260.14
Forward PE	92.56
Dividend	0.14 (0.07%)
Ex-Dividend Date	Jul 16, 2025

Volume	122,011
Average Volume	223,619
Open	190.05
Previous Close	189.35
Day's Range	190.05 - 193.80
52-Week Range	180.35 - 307.85
Beta	n/a
RSI	42.36
Earnings Date	Jul 28, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 5,476
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543635

Financial Performance

In 2024, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.